Superior Offshore (DEEP) Company warns of liquidity problems. Down to $1.20 from 52-week high of $19.58. Medarex (MEDX) Pfizer ends joint drug trial. Sells off to $7.44 from 52-week high of $18.23.…
Medarex Inc. (NASDAQ: MEDX) Saw shares plummet in pre-market trading. Pfizer Inc. (NYSE: PFE) has ended a Phase III clinical trial of tremelimumab in patients with advanced melanoma after a review of…
Adherex Technologies Inc. (AMEX: ADH) has announced that it has received an orphan drug designation for its ADH-1 from the FDA for the use of ADH-1 in conjunction with melphalan for the…
Douglas A. McIntyre Below are ten of the top analysts calls that247WallSt.com is looking at this morning: Audible (NASDAQ: ADBL) downgraded to Hold from Buy at Citigroup. Google (NASDAQ: GOOG) downgraded to Hold from Buy…
These are not the only pre-market analyst calls that are moving stocks, but these are the calls that 247WallSt.com is focusing on: ADC Telecom (NASDAQ: ADCT) and Arris (NASDAQ: ARRS) raised to…
These are not the only analyst calls impacting stocks pre-market, but these are the top calls that 247WallSt.com is focusing on:Caterpillar (NYSE: CAT) raised to Outperform at Bear Stearns.Eastman Chemical (NYSE: EMN)…
Medarex, Inc. (NASDAQ: MEDX) has announced that it will receive a milestone payment from Amgen (NASDAQ: AMGN). Unfortunately, Medarex said the amount is for an undisclosed sum for advancing an antibody into…
We’ve had a lot of biotech stocks see their shares get the wrath of news over recent days. Now that the November-end NASDAQ Short Interest has been released, we wanted to see…
AMR (AMR) High fuel prices and predictions industry will lose money in Q4. Drops to $17.60 from 52-week high of $41. NCI Building Systems (NCS) Company says it will miss 2008 numbers.…
Below is a snapshot of the individual company news affecting share prices being watched by 247WallSt.com: Amtech Systems (NASDAQ: ASYS) shares up 3% after it announced receipt of a $3.9 million solar…
These are not at all the only analyst calls being covered or making an impact in stocks this morning, but these are the ones 247WallSt.com is focusing on initially this morning: Air…
Medarex inc. (NASDAQ: MEDX) is seeing shares slapped in after-hours trading after the company is issuing disappointing news over the hopes for its Ipilimumab Pivotal Trials in patients with Advanced Metastatic Melanoma. …
Some traders might bother peering at the losses on Medarex (NASDAQ:MEDX), but all we are looking at for the time being is the forward study data and the company’s use of cash…
Douglas A. McIntyre Medarex (NASDAQ:MEDX) is seeing shares being hit by a research note where Banc of America initiated coverage with a "SELL" rating. This is a fairly thin volume stock in pre-market trading, but…
We were screening options activity today and something came up that where bets had significantly grown from our prior coverage. Earlier this year we covered some strange biotech options activity after noting…
